Marijuana Reclassification Could Benefit Cannabis Therapy (CTCO) & Others


Ryan Allway

July 1st, 2014

News, Top Story


It has been reported that the U.S. Food & Drug Administration (“FDA”) will review the medical evidence surrounding the safety and effectiveness of marijuana, which could lead to governmental agencies downgrading the drug’s current status as a Schedule I Controlled Substance, the most dangerous drug classification, according to recent media reports commented upon in a timely press release by Cannabis Therapy Corp. [stockquote symbol=CTCO].

Written testimony provided to a congressional hearing by Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, confirm reports that the DEA has been petitioned to change marijuana’s classification and indicated that the request was sent to the FDA. The FDA responded by beginning an eight-factor analysis including drug abuse potential, pharmacological effects, and health risks.

Currently, marijuana is a Schedule I Controlled Substance, which is defined as a drug that “has no currently accepted medical use … lacks accepted safety for use under medical supervision … and is further undisputed that the drug has at least some potential for abuse sufficient to warrant control”. Other substances unfortunately lumped together under the same classification include dangerous illicit drugs like heroin, MDMA, and LSD.

[stockchart symbol=CTCO]

Cannabis Therapy Corp., a development-stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, THC-free cannabinoid-based medicinal therapies and supplements, could be one of many beneficiaries of such policy changes. The company’s current focus is on THC-free, hemp-based products, to avoid violation of current federal marijuana laws.

“A classification downgrade makes perfect sense given the growing body of evidence to support a wide number of medicinal benefits associated with cannabis extracts and products,” said Cannabis Therapy Corp. President & CEO Soren Mogelsvang. “With 22 states already permitting medical marijuana and two of them … allowing recreational use, it’s clearly the time for a reconciliation.”

The differences between U.S. federal law and U.S. state law have been a source of confusion for medical marijuana patients, law enforcement, and companies trying to navigate a state-endorsed industry that is at odds with federal law. New federal laws governing the use, manufacturing and distribution of medical marijuana products would remove these uncertainties and provide assurance for the booming cannabis industry – particularly, the stakeholders, public and private companies and investors operating in the sector.

Cannabis Therapy Corp. is currently focused on using industrial hemp for their product development.  Hemp is a type of cannabis with low THC content and hemp foods have already been fully legalized under federal law following the February 2004 court case of HIA v. DEA, where a judged ruled that the DEA could not regulate natural THC that’s not contained within or derived from marijuana.

“Once everyone is on the same page, we can really move ahead and build a lawful and responsible industry that can deliver health benefits and revenues in a win-win environment for both consumers and stakeholders alike,” added Dr. Mogelsvang.

For more information on Cannabis Therapy, see the following resources:

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading